RMD 1.05% $37.39 resmed inc

ResMed's profit down despite revenue rise, page-12

  1. 3,251 Posts.
    lightbulb Created with Sketch. 71
    From the free articles on MF
    Edward Vesely: ResMed Inc.
    (CHESS) (ASX: RMD)

    ResMed recently reported its financial results for the quarter ending 30 September 2016 showing revenue had increased by 13 percent. Margins were also up on the prior corresponding period, despite a fall in net income of 8.2%.

    Looking forward, the company’s recent Brightree acquisition puts ResMed in a good place with double-digit earnings growth expected from its new investment in the years ahead. ResMed’s shares have fallen almost 16% from recent highs in early August, which makes this a good time to start or add to your position.
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.39
Change
0.390(1.05%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.30 $37.39 $37.07 $9.449M 253.3K

Buyers (Bids)

No. Vol. Price($)
1 44 $37.32
 

Sellers (Offers)

Price($) Vol. No.
$37.39 2573 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.